Abstract: Methods, compositions and products for preventing skin tumor formation or inhibiting the development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an ? adrenergic receptor agonist, such as brimonidine.
Type:
Grant
Filed:
June 29, 2011
Date of Patent:
January 31, 2017
Assignee:
Galderma Research & Development
Inventors:
Guy Bouvier, Matthew James Leoni, Michael Graeber
Abstract: The present invention is directed to an anhydrous glossy composition which is long wearing and transfer resistant, while at the same time providing superior comfort, non-tacky feel and cushioning, the composition containing (a) at least one siloxysilicate resin; (b) at least one polyorganosiloxane-containing polymer; (c) at least one volatile solvent; (d) at least one non-volatile solvent having more than one phenyl group; and (e) optionally, at least one colorant; and wherein the ratio by weight of (b) to (a) is greater than or equal to 1.